Application no. and date | 18169942.2 (espacenet) (Federated) (European Patent Register), 20130425 | Patent/reg. no. and date | DK/EP 3431492, 20201223 | Publication date | 20190123 | Priority no. and date | US 201261639637 P, 20120427 | EP pub. no. and date |
EP 3431492 20190123 | Effective date | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK, Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | Applicant ref. no. | 1573539 | Inventor | ARMITAGE, Richard J., 5840 Packard Lane
Bainbridge Island, WA 98110, US, DANTZLER, Jeff, 14012 Wayne Pl. N.
Seattle, WA 98133, US, CLARK, Rutilio, 5335 Old Mill Road NE
Bainbridge Island, WA 98110, US, ANDERSEN, Mette Dahl, Novo Nordisk A/S Novo Allé, 2880 Bagsværd, DK | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61P 13/12 (2006.01) , A61P 17/00 (2006.01) , A61P 19/02 (2006.01) , A61P 21/00 (2006.01) , A61P 25/00 (2006.01) , A61P 27/02 (2006.01) , A61P 3/04 (2006.01) , A61P 3/10 (2006.01) , A61P 5/16 (2006.01) , A61P 5/38 (2006.01) , C07K 14/28 (2006.01) , C07K 14/70 (2006.01) , C07K 14/705 (2006.01) , C07K 16/28 (2006.01) | Title | HUMANE CD30-LIGANDANTIGEN-BINDENDE PROTEINER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|